Tashkent, Uzbekistan (UzDaily.com) -- Eight more children suffered from taking Doc-1 Max syrup. Seven children were injured in Syrdarya region.

Oltina Esanova, deputy head of the regional health department, said that seven children suffered from taking Doc-1 Max syrup in Syrdarya region.

She noted that four children recovered and were discharged. Three children are in the intensive care unit.

According to UzA, a three-year-old boy from Kuvasay, Ferghana region, was hospitalized with signs of acute poisoning after taking Doc-1 Max syrup. At that time he was in critical condition.

Officially, 19 children who took syrup from the Indian manufacturer Marion Biotech died in Uzbekistan. It is reported that the composition of the batch of the drug contained ethylene glycol in a volume of 300 times more than the norm provided for by medical regulations. Instead, it should have contained propylene glycol.

The Minister of Health of Uzbekistan, Amrillo Inoyatov, sent a letter to pharmacies and instructed them to suspend the sale of all medicines imported by Quramax in 2022.

The letter notes that according to the results of quality control of Doc-1 Max and Ambronol preparations, the laboratory for quality control and standardization of medicines revealed a discrepancy between the composition specified in the regulatory document.

It has been established that some series of these drugs contain ethylene glycol and diethylene glycol instead of propylene glycol or together with it, the letter notes.

On 29 December, a lawsuit was filed with the Tashkent City Court to cancel registration certificates for these drugs.